World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia. Geneva, Switzerland: World Health Organization; 2011.
ShanNZhangXXiaoX. The role of laminin α4 in human umbilical vein endothelial cells and pathological mechanism of preeclampsia. Reprod Sci. 2015;22(8):969–979.
4.
KovoMSchreiberLElyashivOBen-HaroushAAbrahamGBarJ. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia. Reprod Sci. 2015; 22(3):316–321.
5.
McCarthyFPDoyleAKhashanASKennyLC. Altered maternal plasma glycogen phosphorylase isoenzyme BB as a biomarker for preeclampsia and small for gestational age. Reprod Sci. 2016; 23(6):738–747.
6.
OztasEOzlerSErsoyAO. Placental ADAMTS-12 levels in the pathogenesis of preeclampsia and intrahepatic cholestasis of pregnancy. Reprod Sci. 2016 ;23(4):475–481.
7.
SongJLiYAnRF. Identification of early-onset preeclampsia-related genes and microRNAs by bioinformatics approaches. Reprod Sci. 2015;22(8):954–963.
8.
ShinEKKangHYYangHJungEMJeungEB. The regulation of fatty acid oxidation in human preeclampsia. Reprod Sci. 2016; 23(10):1422–1433.
9.
JulianCGPedersenBSSalmonCS. Unique DNA methylation patterns in offspring of hypertensive pregnancy. Clin Transl Sci. 2015;8(6):740–745.
10.
MousaAAArcherKJCappelloR. DNA methylation is altered in maternal blood vessels of women with preeclampsia. Reprod Sci. 2012; 19(12):1332–1342.
11.
KosickaKPaczkowskaJGłówkaFK. HSD11B2, RUNX3, and LINE-1 methylation in placental DNA of hypertensive disorders of pregnancy patients. Reprod Sci. 2017; 24(11):1520–1531.